4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-019257
Chief Executive Officer gave up 10,269 shares (to pay taxes)
- Chief Executive Officer acquired 35,039 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X04/rdgdoc.xml…